Emerging drugs which target the renin–angiotensin–aldosterone system

By Steckelings Ulrike Muscha   Paulis Ludovit   Unger Thomas   Bader Michael  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 619-630

Informa Healthcare

Access to resources Recommend Favorite

Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 981-1004

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic polymorphisms related to the renin–angiotensin–aldosterone system and response to antihypertensive drugs

By Taverne Kim   de Groot Mark   de Boer Anthonius   Klungel Olaf  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 4, 2010-04 ,pp. : 439-460

Informa Healthcare

Access to resources Recommend Favorite

Impact of Inhibitors of the Renin-Angiotensin-Aldosterone System on Liver Fibrosis and Portal Hypertension

By  

Current Medicinal Chemistry, Vol. 13, Iss. 30, 2006-01 ,pp. : 3649-3661

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of the renin–angiotensin–aldosterone system in sepsis: a new therapeutic approach?

By Salgado Diamantino Ribeiro   Rocco José Rodolfo   Silva Eliézer   Vincent Jean-Louis  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 1, 2010-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite